Please take a moment to complete the conference evaluation survey.
ISMB 2014 Online Proceedings available at: http://bioinformatics.oxfordjournals.org/content/30/12.toc
Have a look at the conference photo's
See you next year in Dublin,
Congratulations to all the ISMB 2014 Award Winners
The Intelligent Systems for Molecular Biology (ISMB) conference brings together computational biology researchers of every career stage from around the world. Hosted by the International Society for Computational Biology (ISCB), ISMB has grown over 22 years to become the world's largest bioinformatics/computational biology conference.
ISMB attracts top international scientists in the life sciences and offers a strong scientific program and the broadest scope of any international bioinformatics/computational biology. Topics of interest include sequence analysis, evolution and phylogeny, comparative genomics, protein structure, molecular and supramolecular dynamics, molecular evolution, gene regulation and transcriptomics, RNA biology, proteomics, systems biology, ontologies, databases and data integration, text mining and information extraction, and human health.
In addition, join us prior to ISMB on July 11 & 12 to participate in the Special Interest Group Meetings, Satellite Meetings,Student Council Symposium and Tutorials.
Attend ISMB July 13-15, 2014 to present your research, learn about the latest developments in the field, network with colleagues, and help shape the future of computational biology and bioinformatics!
Dr. Robert Langer
Department of Chemical Engineering
Massachusetts Institute of Technology
Cambridge, United States
Presentation Title: Biomaterials and biotechnology: From the discovery of the first angiogenesis inhibitors to the development of controlled drug delivery systems and the foundation of tissue engineering
Presentation Time: Tuesday July 15, 9:00 am - 10:00 am
Advanced drug delivery systems are having an enormous impact on human health. We start by discussing our early research on developing the first controlled release systems for macromolecules and the isolation of angiogenesis inhibitors and how these led to numerous new therapies. For example, new drug delivery technologies including nanoparticles and nanotechnology are now being studied for use treating cancer and other illnesses. We then discuss ways of developing novel microchips for drug delivery. Approaches for creating new biomaterials are then evaluated and examples where such materials are used in brain cancer and shape memory applications are discussed. Finally, by combining mammalian cells, including stem cells, with synthetic polymers, new approaches for engineering tissues are being developed that may someday help in various disease. Examples in the areas of cartilage, skin, blood vessels and spinal cord repair are discussed.
Robert S. Langer is the David H. Koch Institute Professor (there are 11 Institute Professors at MIT; being an Institute Professor is the highest honor that can be awarded to a faculty member). Dr. Langer has written over 1,230 articles. He also has 1,026 patents (512 issued) worldwide. Dr. Langer's patents have been licensed or sublicensed to over 250 pharmaceutical, chemical, biotechnology and medical device companies. He is the most cited engineer in history.
He served as a member of the United States Food and Drug Administration's SCIENCE Board, the FDA's highest advisory board, from 1995 -- 2002 and as its Chairman from 1999-2002.
Dr. Langer has received over 220 major awards. He is one of 7 individuals to have received both the United States National Medal of Science (2006) and the United States National Medal of Technology and Innovation (2011). He also received the 2002 Charles Stark Draper Prize, considered the equivalent of the Nobel Prize for engineers, the 2008 Millennium Prize, the world's largest technology prize, the 2012 Priestley Medal, the highest award of the American Chemical Society, the 2013 Wolf Prize in Chemistry and the 2014 Breakthrough Prize in Life Sciences. He is the also the only engineer to receive the Gairdner Foundation International Award; 82 recipients of this award have subsequently received a Nobel Prize. Among numerous other awards Langer has received are the Dickson Prize for Science (2002), Heinz Award for Technology, Economy and Employment (2003), the Harvey Prize (2003), the John Fritz Award (2003) (given previously to inventors such as Thomas Edison and Orville Wright), the General Motors Kettering Prize for Cancer Research (2004), the Dan David Prize in Materials Science (2005), the Albany Medical Center Prize in Medicine and Biomedical Research (2005), the largest prize in the U.S. for medical research, induction into the National Inventors Hall of Fame (2006), the Max Planck Research Award (2008), the Prince of Asturias Award for Technical and Scientific Research (2008), the Warren Alpert Foundation Prize (2011) and the Terumo International Prize (2012). In 1998, he received the Lemelson-MIT prize, the world's largest prize for invention for being "one of history's most prolific inventors in medicine." In 1989 Dr. Langer was elected to the Institute of Medicine of the National Academy of Sciences, and in 1992 he was elected to both the National Academy of Engineering and to the National Academy of Sciences, and in 2012 he was elected to the National Academy of Inventors.
Forbes Magazine (1999) and Bio World (1990) have named Dr. Langer as one of the 25 most important individuals in biotechnology in the world. Discover Magazine (2002) named him as one of the 20 most important people in this area. Forbes Magazine (2002) selected Dr. Langer as one of the 15 innovators world wide who will reinvent our future. Time Magazine and CNN (2001) named Dr. Langer as one of the 100 most important people in America and one of the 18 top people in science or medicine in America (America's Best). Parade Magazine (2004) selected Dr. Langer as one of 6 "Heroes whose research may save your life." Dr. Langer has received honorary doctorates from Harvard University, the Mt. Sinai School of Medicine, Yale University, the ETH (Switzerland), the Technion (Israel), the Hebrew University of Jerusalem (Israel), the Universite Catholique de Louvain (Belgium), Rensselaer Polytechnic Institute, Willamette University, the University of Liverpool (England), Bates College, the University of Nottingham (England), Albany Medical College, Pennsylvania State University, Northwestern University, Uppsala University (Sweden), Tel Aviv University (Israel), Boston University, Ben Gurion University (Israel), Drexel University and the University of California - San Francisco Medal. He received his Bachelor's Degree from Cornell University in 1970 and his Sc.D. from the Massachusetts Institute of Technology in 1974, both in Chemical Engineering.